Mass Marketing Of Cancer Drugs Is Not Dead; Precision Medicine Shows Limitations With Bristol-Myers Drug

Bristol-Myers Bucks The Trend Toward Precision Medicine by Jonathan D. Rockoff and Peter Loftus.  Wall Street Journal.  March 13, 2016